U.S. markets closed

Becton, Dickinson and Company (BDX)

NYSE - Nasdaq Precio en tiempo real. Divisa en USD.
Añadir a la lista de seguimiento
263.71-0.52 (-0.20%)
Al cierre: 04:00PM EDT
264.17 +0.46 (+0.17%)
Fuera de horario: 06:46PM EDT

Becton, Dickinson and Company

1 Becton Drive
Franklin Lakes, NJ 07417-1880
United States
201 847 6800
https://www.bd.com

Sector(es)Healthcare
IndustriaMedical Instruments & Supplies
Empleados a tiempo completo75,000

Ejecutivos clave

NombreTítuloPagarEjecutadoAño de nacimiento
Mr. Thomas E. Polen Jr.Pres, CEO & Chairman3.69MN/D1973
Mr. Christopher DelOreficeExec. VP & CFO511.65kN/D1971
Mr. Samrat S. Khichi Esq.Exec. VP of Corp. Devel., Public Policy & Regulatory Affairs and Gen. Counsel1.46MN/D1967
Mr. Simon D. CampionExec. VP, Pres of Medical Segment & Interim Pres of Interventional Segment1.31MN/D1971
Mr. Thomas J. SpoerelSr. VP, Controller & Chief Accounting OfficerN/DN/D1978
Ms. Elizabeth McCombsExec. VP & Chief Technology OfficerN/DN/D1976
Dr. Joseph M. Smith F.A.C.C, M.D., Ph.D.Sr. VP, Chief Scientific Officer & Co-Chair of Scientific Advisory BoardN/DN/DN/D
Ms. Denise FlemingExec. VP of Technology & Global Services and Chief Information OfficerN/DN/DN/D
Ms. Francesca M. DeMartinoSr. VP & Head of Investor RelationsN/DN/DN/D
Michelle QuinnSr. VP and Chief Ethics & Compliance OfficerN/DN/DN/D
Los importes son a partir de 31 de diciembre de 2021 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Pago corresponde al salario, las bonificaciones, etc. Ejecutado corresponde al valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.

Gestión corporativa

La calificación ISS Governance QuickScore de Becton, Dickinson and Company a partir del 31 de julio de 2022 es 9. Las puntuaciones principales son Auditoría: 7; Junta: 6; Derechos del accionista: 10; Compensación: 8.

Las puntuaciones de la gestión corporativa son cortesía de Servicios de accionistas institucionales (ISS). Las puntuaciones indican una posición decil en relación con el índice o la región. Una puntuación decil 1 indica que el riesgo de gestión es menor, mientras que una puntuación decil 10 indica que el riesgo de gestión es mayor.